相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 技术资料
- 保存条件:
Powder: -20°C, 3 years; 4°C, 2 years.In solvent: -80°C, 6 months; -20°C, 1 month.
- 英文名:
JNJ 28431754 hemihydrate
- 库存:
货期:1-2天
- 供应商:
MedChemExpress LLC
- CAS号:
928672-86-0
- 规格:
10 mM * 1 mL/100 mg/500 mg/1 g
| 规格: | 10 mM * 1 mL | 产品价格: | ¥440.0 |
|---|---|---|---|
| 规格: | 100 mg | 产品价格: | ¥400.0 |
| 规格: | 500 mg | 产品价格: | ¥1000.0 |
| 规格: | 1 g | 产品价格: | ¥1500.0 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
Canagliflozin hemihydrate
CAS No. : 928672-86-0
MCE 国际站:Canagliflozin hemihydrate
产品活性:Canagliflozin hemihydrate (JNJ28431754 hemihydrate) 是一种选择性的 SGLT2 抑制剂,作用于表达 mSGLT2,rSGLT2 和 hSGLT2 的 CHO细胞,IC50 分别为 2 nM,3.7 nM 和 4.4 nM。
研究领域:Membrane Transporter/Ion Channel
作用靶点:SGLT
In Vitro: Canagliflozin inhibits Na+-dependent 14C-AMG uptake in CHO-hSGLT2 cells, with an IC50 of 4.4±1.2 nM. Similar IC50 values are obtained in CHO-rSGLT2 and CHO-mSGLT2 cells (IC50 = 3.7 and 2.0 nM for rat and mouse SGLT2, respectively). Canagliflozin inhibits 14C-AMG uptake in CHO-hSGLT1 and mSGLT1 cells with IC50 of 684±159 nM and >1,000 nM, respectively.
In Vivo: Canagliflozin (30 mg/kg treatment for 4 weeks) reduces blood glucose (BG) levels, respiratory exchange ratio, and body weight gain in DIO mice.
Canagliflozin (3 mg/kg for 3 weeks) increases urinary glucose excretion (UGE) with no significant change in total food intake compared with that in vehicle-treated rats, leading to a decrease in body weight In ZF rats.
相关产品:Drug Repurposing Compound Library Plus | FDA-Approved Drug Library Plus | FDA-Approved Drug Library Mini | Bioactive Compound Library Plus | Membrane Transporter/Ion Channel Compound Library | FDA-Approved Drug Library | Anti-Cancer Compound Library | Antiviral Compound Library | Drug Repurposing Compound Library | Anti-diabetic Compound Library | Anti-COVID-19 Compound Library | Orally Active Compound Library | FDA Approved & Pharmacopeial Drug Library | Drug-Induced Liver Injury (DILI) Compound Library | Anti-Cancer Metabolism Compound Library | Anti-Obesity Compound Library | Children’s Drug Library | EMA-Approved Drug Library | FDA-Approved Anticancer Drug Library | Heterocyclic Compound Library | Off-patent Drug Library | Membrane Protein-targeted Compound Library | Membrane Receptor-targeted Compound Library | Highly Selective Inhibitors Library | Empagliflozin | Dapagliflozin | Canagliflozin | Phloretin | Ertugliflozin | Phlorizin | Sotagliflozin | Mizagliflozin | Ipragliflozin | Tofogliflozin (hydrate) | Licogliflozin | Trilobatin | KGA-2727 | Remogliflozin etabonate | Velagliflozin | Dapagliflozin impurity | Enavogliflozin | Henagliflozin | Kushenol K | Luseogliflozin hydrate | LX2761 | Rongliflozin
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
技术资料暂无技术资料 索取技术资料

















